Was Jim Cramer Right About These 9 Stocks?

8. Pfizer Inc. (NYSE:PFE)

Number of Hedge Fund Holders: 99

In that older episode, a viewer asked whether it was time to sell or hold shares of Pfizer Inc. (NYSE:PFE), a stock struggling with post-COVID uncertainty and weak pipeline sentiment. Cramer acknowledged the challenges but urged patience, highlighting the company’s acquisition of Seagen:

“I think we’re going to see some results from Seagen — remember they bought Seattle Genetics. You’ve got that yield, they’re paying you to wait. It’s kind of like a CD with maybe some upside.”

He said to be patient with the Seagen deal, but PFE is down -20.52%, showing it was the wrong call.

Pfizer Inc. (NYSE:PFE) is a multinational pharmaceutical corporation that develops and manufactures medicines and vaccines across therapeutic areas including oncology, cardiology, and infectious disease.

Cramer hasn’t changed his view on the pharma stock at all. Here’s what he said on May 30:

“Oh, they are. You know something, David, I’m with you. 7% yield. It’s got to be something big coming out of that Seagen acquisition real soon about some hard to beat cancers. I am with Albert Bourla and I am with you. I think we can own the stock of Pfizer.”